China Approves Baxter's $4 Billion Bid for Gambro

China's Ministry of Commerce has approved Baxter International's $4 billion bid for Sweden's Gambro AB provided Baxter sells its global continuous renal replacement therapy (CRRT) business, among other conditions.
Reuters